6MK:FRA
මර්ක් ඖෂධ සමාගම
€129.54
0.00%
(0.00) 1D
වප් 9, 18.13.52 ග්‍රිමවේ+2 · EUR
search
සියලු සංකේත
| සංකේතය | මිල | වෙනස් කිරීම | % වෙනස |
|---|
insights_auto6MK සඳහා ඉහළම ඇතුළාන්තයන් උත්පාදනය කරමින්...
වෙ.පො ප්‍රාග්ධනය
බි359.22
දළ පරිමාව
469.00
හඬ පරිමාණය
0.00
සති-52 ඉහළ
€134.54
සති-52 පහළ
€71.00
සේවකයින් ගණන
ද74
වෙ.පො ප්‍රාග්ධනය
බි359.22
දළ පරිමාව
469.00
හඬ පරිමාණය
0.00
සති-52 ඉහළ
€134.54
සති-52 පහළ
€71.00
සේවකයින් ගණන
ද74
පුවත් සහ කථා
වෙබ් මූලාශ්‍ර සහ ප්‍රවෘත්ති හවුල්කරුවන්ගෙන්
TIKR.com
·
පැය 14කට පෙර
Merck Stock Is Up 38% in 2026 as Investors Pay More for Flat Near-Term Earnings. Here’s Where the Stock Could Go by 2030
The Globe and Mail
·
දින 1කට පෙර
Merck & Company (MRK) Receives a Buy from UBS
Yahoo Finance
·
දින 2කට පෙර
Merck (MRK) Stock Trades Below Fair Value Despite Its 117% Run
Trefis
·
දින 2කට පෙර
Does The Move In Merck Stock Change Anything?
පැතිකඩ
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
මර්ක් ඖෂධ සමාගම ගැන